MUSA
Murphy USA Inc.
MUSA has the edge over TSLA overall, supported by stronger fundamentals and stronger valuation.
TSLA
Tesla, Inc.
TSLA's outlook is improving, though it still trails on the overall score.
MUSA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Healthy | |
| Healthy |
MUSA's revenue, profitability, cash flow and balance sheet are all currently healthy.
TSLA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
TSLA's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
MUSA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $385 | -28% |
| Fair | 15x | $534 | -0.1% |
| Current | 15x | $535 | — |
| Forward | 18x | $535 | — |
| Expensive | 20x | $697 | +30% |
Historical ranges are pointers, not guarantees.
MUSA has the edge over TSLA in the historical PE scenario, which offers more potential upside but is not a forecast.
TSLA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 60x | $54.70 | -86% |
| Fair | 174x | $158 | -60% |
| Forward | 196x | $397 | — |
| Expensive | 415x | $378 | -4.9% |
| Current | 437x | $397 | — |
Historical ranges are pointers, not guarantees.
TSLA's PE is in its expensive range at 437x. If earnings grow as analysts expect, today's price would be 196x next year's earnings, in its fair range.
MUSA Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Stable | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect MUSA's revenue to grow, with its earnings and profitability holding steady. However, they disagree widely on these estimates.
TSLA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
TSLA has the edge over MUSA on the outlook, with more favorable valuation and earnings expectations.
MUSA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $29.88 | -16% |
| Q3 2026 | $35.49 | +50% |
| Q2 2026 | $32.66 | +36% |
| Q1 2026 | $28.75 | +22% |
| Q4 2025 | $24.10 | 0% |
| Q3 2025 | $23.62 | -2.5% |
| Q2 2025 | $24.06 | -2.6% |
| Q1 2025 | $23.62 | -0.8% |
| Q4 2024 | $24.11 | -5.4% |
MUSA has the edge over TSLA on earnings, with more consistent year-over-year improvement.
TSLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.03 | +123% |
| Q3 2026 | $0.91 | -39% |
| Q2 2026 | $1.08 | -38% |
| Q1 2026 | $1.09 | -40% |
| Q4 2025 | $1.08 | -47% |
| Q3 2025 | $1.50 | -59% |
| Q2 2025 | $1.73 | -51% |
| Q1 2025 | $1.82 | -53% |
| Q4 2024 | $2.04 | -53% |
TSLA's earnings per share have fallen from their peak: $0.91 over the past year, against $4.30 in late 2023.
MUSA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $6.9B | +35% |
| Q2 2026 | $6.8B | +36% |
| Q1 2026 | $4.8B | +6.5% |
| Q4 2025 | $4.7B | +0.7% |
| Q3 2025 | $5.1B | -2.5% |
| Q2 2025 | $5B | -8.2% |
| Q1 2025 | $4.5B | -6.6% |
| Q4 2024 | $4.7B | -7.1% |
MUSA's revenue has grown year over year for four quarters in a row: $6.9B last quarter, up 35% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.8% | -0.2 points |
| Q2 2026 | 4.5% | +0.1 points |
| Q1 2026 | 4.3% | +2.3 points |
| Q4 2025 | 4.4% | +0.2 points |
| Q3 2025 | 4% | -0.3 points |
| Q2 2025 | 4.4% | +0.4 points |
| Q1 2025 | 1.9% | -0.2 points |
| Q4 2024 | 4.2% | -0.1 points |
MUSA has the edge over TSLA on profitability, with a higher operating margin.
TSLA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28B | -0.2% |
| Q2 2026 | $28.2B | +26% |
| Q1 2026 | $22.4B | +16% |
| Q4 2025 | $24.9B | -3.1% |
| Q3 2025 | $28.1B | +12% |
| Q2 2025 | $22.5B | -12% |
| Q1 2025 | $19.3B | -9.2% |
| Q4 2024 | $25.7B | +2.1% |
TSLA has the edge over MUSA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.6% | -3.2 points |
| Q2 2026 | 1.4% | -2.7 points |
| Q1 2026 | 4.2% | +2.1 points |
| Q4 2025 | 5.7% | -0.5 points |
| Q3 2025 | 5.8% | -5 points |
| Q2 2025 | 4.1% | -2.2 points |
| Q1 2025 | 2.1% | -3.4 points |
| Q4 2024 | 6.2% | -2 points |
TSLA's operating margin was 2.6% last quarter, down 3.2 points from the same quarter a year ago, near the bottom of its range since 2019.
MUSA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $193.7M | +186% |
| Q2 2026 | $123.3M | -10% |
| Q1 2026 | $221.7M | +445% |
| Q4 2025 | $128.8M | +5.8% |
| Q3 2025 | $67.7M | +3.8% |
| Q2 2025 | $137.1M | -4% |
| Q1 2025 | $40.7M | -32% |
| Q4 2024 | $121.7M | -25% |
MUSA has the edge over TSLA on cash flow, with more consistent year-over-year improvement.
TSLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | -62% |
| Q2 2026 | -$1.1B | -848% |
| Q1 2026 | $1.4B | +117% |
| Q4 2025 | $1.4B | -30% |
| Q3 2025 | $4B | +46% |
| Q2 2025 | $146M | -89% |
| Q1 2025 | $664M | +$3.2B |
| Q4 2024 | $2B | -1.6% |
TSLA still generates free cash flow, though less than at its 2025 peak: $3.3B over the past year.
MUSA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -192K shares |
| 1 year | -4.5% | -872K shares |
| 3 years | -16% | -3.4M shares |
| 5 years | -30% | -7.8M shares |
| Available history | -42% | -13.5M shares |
MUSA has the edge over TSLA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $156.2M |
| Q2 2026 | $82.3M |
| Q1 2026 | $70.5M |
| Q4 2025 | $66.9M |
| Q3 2025 | $219.2M |
| Q2 2025 | $213.8M |
| Q1 2025 | $150M |
| Q4 2024 | $128M |
MUSA spent $376M buying back its own shares over the past year, down 47% from the year before.
TSLA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1M shares |
| 1 year | +0.4% | +15M shares |
| 3 years | +1.4% | +48M shares |
| 5 years | +5.1% | +172M shares |
| Available history | +33% | +886M shares |
TSLA has 3.5B diluted shares, about the same as a year ago.
MUSA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.6x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 1.8x | Healthy |
| Q4 2025 | 2.2x | Moderate |
| Q3 2025 | 2.2x | Moderate |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 2.0x | Healthy |
| Q4 2024 | 1.8x | Healthy |
MUSA's net debt is about 1.6 years of its operating earnings (EBITDA), down from 2.2 years a year ago.
TSLA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
TSLA has the edge over MUSA on leverage, with a lower net debt burden relative to earnings.
MUSA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.9 | Neutral |
| Stochastic | 37.4 | Neutral |
MUSA's weekly RSI is 51 (neutral) and its Stochastic is 37 (neutral).
TSLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 72.6 | Neutral |
TSLA's weekly RSI is 54 (neutral) and its Stochastic is 73 (neutral).
MUSA PE vs Consumer Cyclical Sector
| Metric | MUSA | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 18x | 16% below |
| PE % | 50 | 47 | 3 pts above |
MUSA has the edge over TSLA on valuation relative to its sector.
TSLA PE vs Consumer Cyclical Sector
| Metric | TSLA | Sector median | Relative |
|---|---|---|---|
| PE | 437x | 18x | 2,324% above |
| PE % | 84 | 47 | 37 pts above |
TSLA is trading at 437x earnings, a 2324% premium to the Consumer Cyclical sector's median of 18x.
MUSA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $528.7 | 1.1% above |
| 20 week MA | $547.2 | 2.3% below |
| 50 week MA | $503.4 | 6.2% above |
| 100 week MA | $467.6 | 14% above |
| 200 week MA | $425.8 | 26% above |
MUSA's trend is mixed: it's above four of its five weekly moving averages, and 26% above its 200-week average.
TSLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $376.0 | 5.7% above |
| 20 week MA | $364.0 | 9.2% above |
| 50 week MA | $393.6 | 1% above |
| 100 week MA | $372.1 | 6.8% above |
| 200 week MA | $296.9 | 34% above |
TSLA has the edge over MUSA on trend strength, trading above more of its moving averages.
MUSA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $119.5 | $130.2 | +8.9% |
| 2021 | $130.2 | $191.6 | +47% |
| 2022 | $191.6 | $293.4 | +53% |
| 2023 | $293.4 | $356.6 | +22% |
| 2024 | $356.6 | $505.2 | +42% |
| 2025 | $505.2 | $405.0 | -20% |
| 2026 YTD | $405.0 | $534.7 | +32% |
MUSA has the edge over TSLA on returns for 2026, with the stronger performance.
TSLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.7 | $220.6 | +669% |
| 2021 | $220.6 | $355.7 | +61% |
| 2022 | $355.7 | $123.2 | -65% |
| 2023 | $123.2 | $248.5 | +102% |
| 2024 | $248.5 | $431.7 | +74% |
| 2025 | $431.7 | $475.2 | +10% |
| 2026 YTD | $475.2 | $397.5 | -16% |
TSLA's yearly returns have swung widely, from +669% in 2020 to −65% in 2022. It's down 16% so far in 2026.